Testing effectiveness (Phase 2)Ended earlyNCT01994291
What this trial is testing
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Who this might be right for
Macular Edema, Diabetic
Pfizer 199